Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors
about
Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?Killing me softly--future challenges in apoptosis researchDamage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate.Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesPharmacogenetics of anticancer drugs in non-Hodgkin lymphomas.Targeting apoptosis in cancer chemotherapy.Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1.Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.The mesenchymal tumor microenvironment: a drug-resistant niche.Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activationbeta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.The role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells.Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.Novel Approaches to Apoptosis-Inducing Therapies.Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.A New View of Pathway-Driven Drug Resistance in Tumor Proliferation.Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo.Functional polymorphisms of ITGB1 are associated with clinical outcome of Chinese patients with resected colorectal cancer.β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak.Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome. A case report.Cancer stem cells as key drivers of tumour progression.
P2860
Q24801341-023C6D0F-5C51-4D0F-B835-67CBCF7C8A45Q27025213-34F0FBCE-6EA5-47B2-AF97-7C5125087317Q28364008-B9BA2EDE-9C56-4512-AC13-DD9B92DA6845Q34158454-262A406D-48A8-4FCB-A474-B4AB5C499600Q34447178-B8B58AD4-668A-4BE1-B95B-64F713CA3BCBQ34568964-A4F529BA-DACE-490A-9C36-249B486358E8Q34781192-A1D1CF93-BEAC-4E63-B9D1-C5875FEBA964Q35567260-1C0D260A-AF82-486D-81A8-77754DA109ECQ36187755-32211CC4-ECEB-4653-9E0E-6BBF4CEC1905Q36976151-5C8721F2-C9A5-45C8-9A2F-EB6C140173D9Q37234641-04D1B1E4-C0E6-4A28-B788-D31A68ADB16FQ37301734-27352A31-A0E5-435D-9BD8-16149992C3FFQ37460431-46061DB5-3B1D-4B5C-8497-4DEA1C115839Q38041729-ADA805FF-2633-4FB3-B132-3EEA0A0E39C7Q38132359-E7613B8A-0A8A-4248-805D-DA2A99C763F5Q38734491-359130B3-2609-4390-9CB7-3E0DD9A90392Q38891257-E7E2EE20-9F77-4C7B-BAB5-2FC1B8D9A0FFQ38936710-4A24DA1A-CF1D-48F7-95B6-A57FC4E65644Q39003420-D5284DE8-8D30-41B9-8448-EF1093F0F5ACQ39155018-3DDB2284-0B00-4925-B137-45514EBB78BDQ40059658-A007635E-234F-4A8F-9459-C83DE69F909BQ40749276-B3DDC1BF-4919-47B1-AC9D-09C5CAA35930Q41038707-CC331DF2-7758-451B-A604-BD50C88F73A6Q41122817-7A2507BA-6B5A-4414-ACC4-CA845DF9ED99Q43830983-FD0BDAF6-B811-4726-9063-BC9EA5E434CCQ53407877-C99C98DB-468F-49A1-BE28-CB211FABD9B8Q55122201-ECD81B10-8D2E-451D-82A2-EFB63A379310
P2860
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Epigenetic determinants of res ...... mor microenvironmental factors
@ast
Epigenetic determinants of res ...... mor microenvironmental factors
@en
Epigenetic determinants of res ...... mor microenvironmental factors
@nl
type
label
Epigenetic determinants of res ...... mor microenvironmental factors
@ast
Epigenetic determinants of res ...... mor microenvironmental factors
@en
Epigenetic determinants of res ...... mor microenvironmental factors
@nl
prefLabel
Epigenetic determinants of res ...... mor microenvironmental factors
@ast
Epigenetic determinants of res ...... mor microenvironmental factors
@en
Epigenetic determinants of res ...... mor microenvironmental factors
@nl
P3181
P356
P1476
Epigenetic determinants of res ...... mor microenvironmental factors
@en
P2093
J A Hickman
S T Taylor
P3181
P356
10.1093/JNCI/92.1.18
P407
P577
2000-01-05T00:00:00Z